Pages that link to "Q34211735"
Jump to navigation
Jump to search
The following pages link to Effects of Various Flavonoids on theα-Synuclein Fibrillation Process (Q34211735):
Displaying 22 items.
- Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide (Q28818425) (← links)
- Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates (Q34074933) (← links)
- Anti-fibrillation propensity of a flavonoid baicalein against the fibrils of hen egg white lysozyme: potential therapeutics for lysozyme amyloidosis (Q35837281) (← links)
- Piceatannol and Other Wine Stilbenes: A Pool of Inhibitors against α-Synuclein Aggregation and Cytotoxicity (Q37045173) (← links)
- Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent mol (Q37697439) (← links)
- α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease (Q38669019) (← links)
- How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro (Q38987375) (← links)
- Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity. (Q39659132) (← links)
- In vitro aggregation assays for the characterization of α-synuclein prion-like properties. (Q41821396) (← links)
- A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties (Q42366153) (← links)
- Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice (Q50088901) (← links)
- Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson's disease exposed to apigenin. (Q51807832) (← links)
- Inhibition effects of tanshinone on the aggregation of α-synuclein. (Q52664421) (← links)
- Inhibition of Protein Aggregation by Several Antioxidants. (Q55276020) (← links)
- Exploring the Structural Diversity in Inhibitors of α-Synuclein Amyloidogenic Folding, Aggregation, and Neurotoxicity. (Q55312267) (← links)
- Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases. (Q55709517) (← links)
- Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease (Q64061136) (← links)
- Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity (Q64098158) (← links)
- Dietary Polyphenols-Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review. (Q64914298) (← links)
- The interaction of several herbal extracts with α-synuclein: Fibril formation and surface plasmon resonance analysis. (Q64980851) (← links)
- PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape (Q89879475) (← links)
- Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein (Q92740275) (← links)